Ganga Pharmaceuticals Ltd.
BSE: 539680 | Sector: Health care |
NSE: N.A. | ISIN Code: INE615T01017 |
BSE 00:00 | 05 Jan | 13.93 |
0 (0.00%) |
OPEN
15.30 |
HIGH
15.30 |
LOW
12.55 |
NSE 05:30 | 01 Jan | Ganga Pharmaceuticals Ltd |
OPEN | 15.30 |
PREVIOUS CLOSE | 13.93 |
VOLUME | 16000 |
52-Week high | 16.57 |
52-Week low | 7.80 |
P/E | 154.78 |
Mkt Cap.(Rs cr) | 6 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Ganga Pharmaceuticals Ltd. (GANGAPHARMA) - Net Profit
Net Profit
COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
Cipla | 1047.05 | 12.65 | 1.22 | 2957.93 |
Divi's Lab. | 3385.55 | 49.05 | 1.47 | 2948.54 |
Glenmark Pharma. | 381.40 | -17.60 | -4.41 | 1997.79 |
Glaxosmi. Pharma | 1261.60 | -1.35 | -0.11 | 1690.53 |
Dr Reddy's Labs | 4318.30 | 113.75 | 2.71 | 1623.20 |
Alkem Lab | 2997.60 | -16.20 | -0.54 | 1541.25 |
Aurobindo Pharma | 416.25 | -1.60 | -0.38 | 1454.71 |
Gland Pharma | 1357.10 | 15.55 | 1.16 | 1212.16 |
Torrent Pharma. | 1537.80 | -19.70 | -1.26 | 991.45 |
Sanofi India | 5580.95 | -45.70 | -0.81 | 944.40 |
Ipca Labs. | 850.60 | -13.40 | -1.55 | 870.94 |
Zydus Lifesci. | 430.25 | 4.15 | 0.97 | 857.90 |
Abbott India | 21219.85 | -60.15 | -0.28 | 798.70 |
Laurus Labs | 341.85 | -0.15 | -0.04 | 750.09 |
Ajanta Pharma | 1181.85 | -11.55 | -0.97 | 719.86 |
Apollo Hospitals | 4243.30 | 18.20 | 0.43 | 665.20 |
Pfizer | 4000.70 | -13.75 | -0.34 | 612.56 |
Suven Pharma | 491.30 | 2.30 | 0.47 | 558.10 |
Alembic Pharma | 538.10 | -7.85 | -1.44 | 543.55 |
Glenmark Life | 390.45 | 0.50 | 0.13 | 418.72 |
Quick Links for Ganga Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices